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Abstract
Background: Colorectal Cancer (CRC) is the third most common cancer in Iran and its early detection is necessary. 
This study is based on perception of people in the east of Iran toward CRC screening.
Methods: In a cross-sectional study, 1060 randomly selected individuals who referred to Razavi Hospital of Mashhad, 
Iran, between September the 1st, 2012 and February the 28th, 2013  as patients or their visitors involved in an interview 
to fill a questionnaire on CRC screening. 
Results: The participants’ age ranged from 40 to 88 years (mean= 55). More than 90% had no knowledge of CRC and 
screening tests. The most cited reasons for not having screening tests were “did not have any problem” and “did not 
think it was needed”. Although, older people had more knowledge of CRC (P= 0.033), there was no relationship between 
gender, health insurance status, family history of individuals and their knowledge about CRC (P> 0.050). Employment, 
education and higher income had positive effect on the perception of people toward CRC screening (P< 0.050).
Conclusion: Lack of knowledge in people in lower socio-economical class with limited literacy is the most important 
barrier to CRC screening.  As such, designing educational programs involving physicians and media is important to 
improve CRC screening rates.
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Introduction
The prevalence of Colorectal Cancer (CRC) in Asia is high 
and the number of new cases is rapidly increasing in both 
genders (1–3). In Iran, CRC is the third most common cancer 
in women and fifth in men and is known as the fifth cause of 
cancer death (4). CRC is mostly prevalent in older people but 
in Iran there has been a great rise in its incidence among young 
individuals in recent decades, especially in those with positive 
history of CRC in the first or second degree relatives (4).
The incidence of this malignancy is reducing in many western 
countries, largely due to improvements in treatment and 
increased people’s awareness and early detection. On the other 
hand, the rates continue to increase in communities with less 
social knowledge and more limited health resources (1).
The majority of CRC incidences and deaths can be prevented 
by applying public awareness about cancer prevention and by 
raising the use of available screening tests. 
By screening we are able to find and remove adenomatous 
polyps which are in premalignant state of CRC (5,6). Also 
being screened regularly and at the recommended intervals 
increases the probability of cure with less extensive treatment 
when CRC is present. 
According to American Cancer Society, the US Multi-Society 
Task Force on CRC and the American College of Radiology 
guidelines, screening of adenomatous polyps and CRC in 
average-risk adults should begin at age 50 years with one of 
the following options: 1) annual guaiac Fecal Occult Blood 
Test (gFOBT) or Fecal Immunochemical Test (FIT) or testing 
stool for exfoliated cell DNA, 2) flexible sigmoidoscopy every 
5 years; 3) colonoscopy every 10 years, 4) double-contrast 
barium enema every 5 years, or 5) CT colonography every 5 
years (7–10). 
Previously, several published researches from various 
countries with different races and cultures have reported 
patient barriers to CRC screening as health illiteracy and lack 
of knowledge, negative attitudes about prevention and cancer, 
financial concerns and lack of physician’s recommendation 
for screening tests (2,11–25).
Also, in a study by Beydoun and Beydoun in US, predictors 
of CRC screening behaviors among average-risk older adults 
included older age, male gender, marriage, higher education, 
higher income, white race, non-Hispanic ethnicity, smoking 
history, presence of chronic diseases, family history of CRC, 
usual source of care, physician recommendation, utilization 
of other preventive health services, and health insurance 
coverage (26). There are a few data about CRC screening 
knowledge and attitudes of Iranians in literature and most of 
them include a small sample size (10,27). 
Considering the ethnic and cultural dispersion and 
demographic characteristics of Iran, and lack of a national 
program for CRC screening, we performed the current 
study on a large sample of Eastern Iranian population to 
investigate Persian’s awareness and attitudes toward CRC and 
obstacles to screening.
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Methods
This is a cross-sectional study on 1060 randomly selected 
individuals older than 40 years who referred to Razavi 
Hospital of Mashhad, Iran, between September the 1st, 2012 
and February the 28th, 2013 as patients or their visitors 
involved in a face to face interview by two trained nurses to fill 
a designed questionnaire including demographics, knowledge 
about symptoms, risk factors and screening tests of CRC 
and reasons for not being screened. Also, those aware of the 
screening tests were asked about the way of notification.
CRC risk factors in the questionnaire consisted of 8 items: 1) 
excessive alcohol intake, 2) smoking, 3) obesity, 4) positive 
history of CRC in the first or second degree relatives, 5) high 
calorie diet, 6) high red meat consumption, 7) sedentary life 
style, 8) diets containing high saturated fats (28).
CRC symptoms consisted of  7 items: 1) bloody stool, 2) change 
in bowel habits, 3) weight loss, 4) generalized weakness, 5) 
nausea and vomiting, 6) intermittent abdominal pain, 7) 
abdominal bloating (28).
In our study we evaluated the knowledge about the most 
available CRC screening tests: 1) fecal occult blood test, 2) 
flexible sigmoidoscopy, 3) colonoscopy. 
Since the purpose of this study was finding the knowledge of 
people toward CRC screening, patients with past or present 
history of inflammatory bowel diseases (crohn’s disease 
and ulcerative colitis), CRC or polyps were excluded. After 
interview, every person received a free pamphlet, provided by 
Razavi Hospital CRC Research Group about CRC including 
definition, risk factors, symptoms, importance of screening 
and standard screening tests. 
The study questionnaire followed the constructions of the 
Health Belief Model as a guide for validity (29). Cronbach’s 
alpha was used to evaluate the reliability which was 99%. Data 
were analyzed by descriptive and analytical statistics using 
SPSS 19 (SPSS Inc., Chicago, IL, USA) and a P value of <0.050 
was considered significant. 
To compare the level of knowledge among men and women, 
employment status, insurance status and people in various 
levels of education, Chi-square (for qualitative variables) and 
one way ANOVA (for quantitative variables) tests were used. 
Scoring of different parts of questionnaire was carried out 
according to Table 1.
Results
1060 questionnaires were completed by the respondents 59 
of which were excluded due to history of CRC and polyp 
or inflammatory bowel disease. The sample of 1001 people 
consisted of 478 males and 523 females with the age range 
of 40 to 88 years (mean= 55, SD= 10.9). Socio-demographic 
characteristics of the study participants are shown in Table 2.
At the time of this study, most of the participants were 
married (98.0%). The majority of persons had secondary 
school education or less (78.2%) and were employed or retired 
(52.1%) with monthly income of less than 400 US dollars 
(90.5%). Also, 88.3% of individuals had health insurance. 
Forty persons (4.0%) reported a positive history of CRC in 
their first or second degree relatives. In our survey, only 4.2% 
of respondents reported prior screening for CRC and other 
95.8% had never been tested before.
More than 90% of the participants in this study did not have 
any knowledge of CRC risk factors, symptoms or the screening 
tests. Table 3 shows the knowledge of participants about CRC 
and screening tests.
Most of the people mentioned “did not have any symptom or 
Table 1. Scoring of different parts of questionnaire
Part Scoring
Awareness of the risk factors of
CRC
Lack of information= nothing
Aware of 1–2 items= low
Aware of 3–5 items= medium
Aware of 6–8 items= high
Awareness of the symptoms of CRC
Lack of information= nothing
Aware of 1–2 = low
Aware of 3–4 items= medium
Aware of 5–7 items= high
Awareness of the screening tests
Lack of information= nothing
Aware of 1 item= low
Aware of 2 items= medium
Aware of 3 items= high




  Male 478 47.8
  Female 523 52.2





  Diploma or less 783 78.2
  Some college or Bachelor’s degree 190 19.0
  Master’s degree or more 28 2.8
Employment status
  Employed or Retired 522 52.1
  Unemployed 479 47.9
Monthly income (US dollar)
  <200 215 21.5
  200–400 691 69.0
  >400 76 7.6
  Missing 19 1.9
Family history of CRC
  Yes 40 4.0
  No 961 96.0
Health insurance
  Yes 884 88.3
  No 117 11.7
Prior history of CRC screening
  Yes 42 4.2
  No 959 95.8
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problem” and “did not think it was needed” as the main reasons 
for not having CRC screening tests (reported in 40.1%, 32.5% 
respectively). Also 12.7% of the respondents cited “physician 
did not recommend the test”, as their reason. Findings showed 
that “fear of the screening test”, “fear of advanced CRC” and 
“the cost of test”, were the least cited barriers for participation 
in CRC screening tests. 0.5.3% of the participants who had 
some knowledge about screening tests of CRC, expressed 
university education, physician recommendation, family 
members, magazines and newspapers, as the primary sources 
of their notification. 
Analysis of data proved that there was no relationship between 
variables such as gender, health insurance status, family 
history and knowledge of people about CRC risk factors and 
symptoms (Table 4).
Although having a positive family history of CRC did not 
increase the clinical knowledge among high-risk group, 
there was a significant association (P= 0.012) between family 
history and awareness of the screening tests (Table 4).
Comparison between knowledge of risk factors and symptoms 
of CRC and age of participants indicated a significant 
difference (P= 0.031) as the older people had more knowledge. 
Employment, education and higher incomes had positive 
influence on the perception of individuals toward CRC risk 
factors, symptoms and screening tests, too (Table 4).
Discussion
The findings of this study demonstrated that 95.8% of our 
people have never had screening for CRC before and even, 
more than 90% did not have any knowledge of CRC risk 
factors, symptoms or the screening tests. This data is far from 
the current situation in the US where about 65% of people 
aged 50 or older have received CRC screening test consistent 
Table 3. Distribution of knowledge score toward risk factors and 







High 0.2% 0.1% 0.3%
Medium 0.8% 0.7% 0.8%
Low 8.0% 7.1% 4.2%
Nothing 91.0% 92.1% 94.7%












Gender 0.546 0.178 0.532
Age 0.032 0.038 0.236
Family History 0.272 0.380 0.011
Health Insurance 0.402 0.253 0.339
Marital Statues 0.018 0.957 0.158
Employment 0.003 0.011 0.005
Education 0.001 0.001 0.001
Income 0.001 0.002 0.031
with current guidelines and it is still below target rates (30).
Like other studies, age, has been found as an important 
factor in the knowledge of people with rates higher among 
older individuals, which can be due to increased risk of co-
morbidities in older people that force them to seek medical 
advice more than the others, although this must be evaluated 
in further studies with emphasizing on relationship between 
co-morbidities and CRC screening rate (15,16,31).
One of the most important barriers to CRC screening in our 
population is limited literacy that deprives them of general or 
particular awareness and information. This is consistent with 
the results of the other studies (13,20,23,26,27,32).
As mentioned in prior studies (2,10,13,26,33), we also realized 
that employment and higher income can be promoters to 
encourage average risk people to undergo screening and on 
the other hand, low socio-economic condition specially in 
rural areas can be a barrier in this regard.
Unlike other studies that reported absence of health insurance 
as a threat, we did not find any correlation between health 
insurance and participation in screening which can be due to 
lack of enough coverage for the expensive screening tests by 
the insurance organizations in Iran (2,11,15,26,31).
Although positive family history of CRC did not increase the 
knowledge of our population about CRC symptoms and risk 
factors, it could raise their awareness of screening tests that 
was consistent with findings in previous studies (10,15,26).
Most of the individuals in our survey perceived themselves 
to be in good health and did not think the screening tests 
were needed. This fact accompanying by failure of physician 
recommendation were the most cited reasons for not 
having screening tests which shows that perception of CRC 
risk in general population and healthcare system plays an 
important role in the tendency of adults toward screening 
and prevention. This is consistently reported in several other 
papers too (10,11,14,16,19,20,23,24,27,31,32,33–35).
In a study by Omran and Ismail in Jordan, the most 
common sources of information about CRC screening were 
respectively family members, newspapers and magazines, 
television or radio and physicians (25). In accordance to 
their findings, in our study those who had some knowledge 
about screening tests of CRC, expressed university education, 
physician recommendation, family members, magazines 
and newspapers, respectively as the primary sources of their 
notification that explains the remarkable role of educational 
and healthcare system in the improvement of public 
knowledge and perception toward CRC screening.
In this study we proposed gFOBT instead of FIT as a tool 
for CRC screening, because it’s cheaper and more available 
in primary laboratories in Iran, particularly in small cities. 
Although FIT, with fewer tests, is more sensitive and needs no 
dietary restriction (36).
In our study we had limitation in evaluating the influence 
of our CRC pamphlet (cited in methodology section) on 
improvement of people’s awareness, therefore further studies 
must be planned to investigate the effect of such educational 
programs on medical knowledge of people to persuade them 
to undergo screening tests. Also the second barrier to this 
research was finding the exact number of patients in our 
sample that referred to Razavi hospital and separating the 
results to two groups (patients and general population) to 
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remove the probable bias of selection. 
Conclusion
Lack of knowledge in people, particularly those in lower socio-
economical class with limited literacy is the most important 
barrier to CRC screening. So, designing educational programs 
involving physicians and media is important to improve 
CRC screening rates. In a developing country like Iran with 
an acceptable infrastructure of healthcare system, training 
family physicians on CRC screening based on national or 
international guidelines to perform office-based fecal occult 
blood test and refer patients with a positive test for a diagnostic 
colonoscopy can be a useful strategy.
Acknowledgments
We thank the Research and Education Department of Razavi 
Hospital for funding and support of this study. We also thank 
Dr Ramin Sadeghi for revising the manuscript. Authors 
acknowledge the CRC Research Group of Razavi Hospital 
who provided help during the research. 
Ethical issues
All the patients were fully informed and ethical consent was obtained. 
Competing interests 
The authors declare that they have no competing interests.
Authors’ contributions
FB and KG were the main investigators, participated in the design and 
conducting the study, drafted and edited the manuscript. AI participated in the 
design of the study and conducted the statistical analysis. SA, NJ, FK, AA, MV 
and TT participated in the design and conducted the data gathering for the 
study. HA participated in the design of the study and edited the manuscript 
for final submission. All authors read and approved the final manuscript. FB 
is the study guarantors.
Authors’ affiliations
Research and Education Department, Razavi Hospital, Mashhad, Iran. 
References
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 
Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90. doi: 
10.3322/caac.20107
2. Sung JJ, Choi SY, Chan FK, Ching JY, Lau JT, Griffiths S. 
Obstacles to colorectal cancer screening in Chinese: a study 
based on the health belief model. Am J Gastroenterol 2008; 103: 
974–81. doi: 10.1111/j.1572-0241.2007.01649.x
3. Tu SP, Taylor V, Yasui Y, Chun A, Yip MP, Acorda E, et al. 
Promoting culturally appropriate colorectal cancer screening 
through a health educator. Cancer 2006; 107: 959–66. doi: 
10.1002/cncr.22091
4. Pourhoseingholi MA, Zali MR. Colorectal cancer screening: Time 
for action in Iran. World J Gastrointest Oncol 2012; 4: 82–3. doi: 
10.4251/wjgo.v4.i4.82
5. Consolo P, Luigiano C, Strangio G, Scaffidi MG, Giacobbe G, 
Di Giuseppe G, et al. Efficacy, risk factors and complications of 
endoscopic polypectomy: ten year experience at a single center. 
World journal of gastroenterology: WJG 2008; 14: 2364. doi: 
10.3748/wjg.14.2364
6. Zauber AG, Winawer SJ, O’Brien MJ, Lansdorp-Vogelaar I, van 
Ballegooijen M, Hankey BF, et al. Colonoscopic polypectomy 
and long-term prevention of colorectal-cancer deaths. N Engl J 
Med 2012; 366: 687–96.  doi:  10.1056/NEJMoa1100370
7. Smith RA, Cokkinides V, Brawley OW. Cancer Screening in 
the United States, 2012 A Review of Current American Cancer 
Society Guidelines and Current Issues in Cancer Screening. CA 
Cancer J Clin 2012; 62: 129-42. doi: 10.3322/caac.20143
8. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, 
Andrews KS, et al. Screening and Surveillance for the Early 
Detection of Colorectal Cancer and Adenomatous Polyps, 2008: 
A Joint Guideline from the American Cancer Society, the US 
Multi-Society Task Force on Colorectal Cancer, and the American 
College of Radiology. CA Cancer J Clin 2008; 58: 130–60. doi: 
10.3322/ca.2007.0018
9. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. 
Colorectal cancer screening and surveillance: clinical guidelines 
and rationale—update based on new evidence. Gastroenterology 
2003; 124: 544–60. doi: 10.1053/gast.2003.50044
10. Salimzadeh H, Delavari A, Montazeri A, Mirzazadeh A. 
Knowledge and practice of iranians toward colorectal cancer, 
and barriers to screening. Int J Prev Med 2012; 3: 29–35.
11. O’Malley A, Beaton E, Yabroff K, Abramson R, Mandelblatt J. 
Patient and provider barriers to colorectal cancer screening in the 
primary care safety-net. Prev Med 2004; 39: 56. doi: 10.1016/j.
ypmed.2004.02.022
12. James AS, Campbell MK, Hudson MA. Perceived barriers and 
benefits to colon cancer screening among African Americans 
in North Carolina: how does perception relate to screening 
behavior? Cancer Epidemiol Biomarkers Prev 2002; 11: 529–34.
13. Green PM, Kelly BA. Colorectal cancer knowledge, perceptions, 
and behaviors in African Americans. Cancer Nurs 2004; 27: 206–
15.  doi: 10.1097/00002820-200405000-00004
14. Jones RM, Woolf SH, Cunningham TD, Johnson RE, Krist AH, 
Rothemich SF, et al. The relative importance of patient-reported 
barriers to colorectal cancer screening. Am J Prev Med 2010; 
38: 499–507.
15. Tessaro I, Mangone C, Parkar I, Pawar V. Peer reviewed: 
knowledge, barriers, and predictors of colorectal cancer 
screening in an appalachian church population. Prev Chronic 
Dis 2006; 3: A123.
16. Berkowitz Z, Hawkins NA, Peipins LA, White MC, Nadel MR. 
Beliefs, risk perceptions, and gaps in knowledge as barriers to 
colorectal cancer screening in older adults. J Am Geriatr Soc 
2008; 56: 307–14. doi: 10.1111/j.1532-5415.2007.01547.x
17. Holmes-Rovner M, Williams GA, Hoppough S, Quillan L, Butler R, 
Given CW. Colorectal cancer screening barriers in persons with 
low income. Cancer Pract 2002; 10: 240–7. doi: 10.1046/j.1523-
5394.2002.105003.x
18. Tang TS, Solomon LJ, McCracken LM. Barriers to Fecal Occult 
Blood Testing and Sigmoidoscopy Among Older Chinese-
American Women. Cancer Pract 2001; 9: 277–82. doi: 
10.1046/j.1523-5394.2001.96008.x
19. Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal 
cancer screening among Medicare consumers. Am J Prev Med 
2006; 30: 313. doi: 10.1016/j.amepre.2005.11.006
20. Wee CC, McCarthy EP, Phillips RS. Factors associated 
with colon cancer screening: the role of patient factors and 
physician counseling. Prev Med 2005; 41: 23. doi:10.1016/j.
ypmed.2004.11.004 
21. Greiner KA, Born W, Nollen N, Ahluwalia JS. Knowledge and 
perceptions of colorectal cancer screening among urban African 
Americans. J Gen Intern Med 2005; 20: 977–83. doi: 10.1007/
s11606-005-0244-8
22. Goodman MJ, Ogdie A, Kanamori MJ, Canar J, O’Malley AS. 
Barriers and facilitators of colorectal cancer screening among 
mid-Atlantic Latinos: Focus group findings. Ethn Dis 2006; 16: 
255–61.
23. McCaffery K, Wardle J, Waller J. Knowledge, attitudes, and 
behavioral intentions in relation to the early detection of colorectal 
Bidouei et al.
International Journal of Health Policy and Management, 2014, 3(1), 11–15 15
Implications for policy makers
• There are so many barriers like education, employment 
and income to Colorectal Cancer (CRC) screening in a 
developing country like Iran.
• There is not enough coverage for the expensive screening 
tests by the insurance organizations in Iran. 
• The role of health system infrastructure in screening 
programs’ participation is essential.
• Designing educational programs involving physicians and 
media is important to improve CRC screening rates.
Implications for public
In Iran, Colorectal Cancer (CRC) is the third most common 
cancer in women and fifth in men and is known as the fifth 
cause of cancer death. CRC is mostly prevalent in older 
people but in Iran there has been a great rise in its incidence 
among young individuals in recent decades, especially in 
those with positive history of CRC in the first or second 
degree relatives. The majority of CRC incidences and deaths 
can be prevented by applying public awareness about cancer 
prevention and by raising the use of available screening tests. 
By screening, we are able to find and remove adenomatous 
polyps which are in premalignant state of CRC. Also regular 
screening at recommended intervals improves the probability 
of cure with less extensive treatment when CRC is present.
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